Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

The development of therapeutic cancer vaccines as a means to generate immune reactivity
against tumors has been explored since the early discovery of tumor-specific antigens by …

Messenger RNA (mRNA) has recently emerged as a promising class of nucleic acid therapy,
with the potential to induce protein production to treat and prevent a range of diseases …

Immunotherapy has recently emerged as a powerful tool for cancer treatment. Early clinical
successes from cancer immunotherapy have led to a growing list of FDA approvals, and …

The utility of layer-by-layer (LbL) coated microneedle (MN) skin patches for transdermal drug
delivery has proven to be a promising approach, with advantages over hypodermal injection …

Vaccines are one of the best health care advances ever developed, having led to the
eradication of smallpox and near eradication of polio and diphtheria. While tremendously …

Current vaccine research has shifted from traditional vaccines (ie, whole-killed or live-
attenuated) to subunit vaccines (ie, protein, peptide, or DNA) as the latter is much safer due …

Two different vasoactive intestinal peptide (VIP) amphiphiles have been formulated which
readily form micelles of varying shapes. Interestingly, VIP micelle structure has been found …

Hydrophobically driven self-assembly is a well-understood principle that has been shown to
facilitate micelle formation. Although quite useful, the library of structures accessible is …

Nervous necrosis virus (NNV) has spread throughout the world, affecting more than 120
freshwater and marine fish species. While vaccination effectively prevents disease …